228 related articles for article (PubMed ID: 25276812)
1. Alterations in the anandamide metabolism in the development of neuropathic pain.
Malek N; Kucharczyk M; Starowicz K
Biomed Res Int; 2014; 2014():686908. PubMed ID: 25276812
[TBL] [Abstract][Full Text] [Related]
2. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
3. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
4. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
[TBL] [Abstract][Full Text] [Related]
5. Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.
Starowicz K; Makuch W; Osikowicz M; Piscitelli F; Petrosino S; Di Marzo V; Przewlocka B
Neuropharmacology; 2012 Mar; 62(4):1746-55. PubMed ID: 22178705
[TBL] [Abstract][Full Text] [Related]
6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
7. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
[TBL] [Abstract][Full Text] [Related]
8. Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
Khasabova IA; Holman M; Morse T; Burlakova N; Coicou L; Harding-Rose C; Simone DA; Seybold VS
Neurobiol Dis; 2013 Oct; 58():19-28. PubMed ID: 23644187
[TBL] [Abstract][Full Text] [Related]
9. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
11. Anandamide modulates human sperm motility: implications for men with asthenozoospermia and oligoasthenoteratozoospermia.
Amoako AA; Marczylo TH; Marczylo EL; Elson J; Willets JM; Taylor AH; Konje JC
Hum Reprod; 2013 Aug; 28(8):2058-66. PubMed ID: 23697839
[TBL] [Abstract][Full Text] [Related]
12. MZF1 in the Dorsal Root Ganglia Contributes to the Development and Maintenance of Neuropathic Pain via Regulation of TRPV1.
Xing F; Gu H; Niu Q; Fan X; Wang Z; Yuan J; Li Z; Xu JT; Zhang W
Neural Plast; 2019; 2019():2782417. PubMed ID: 31582966
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Helyes Z; Németh J; Thán M; Bölcskei K; Pintér E; Szolcsányi J
Life Sci; 2003 Sep; 73(18):2345-53. PubMed ID: 12941436
[TBL] [Abstract][Full Text] [Related]
14. Activity of anandamide (AEA) metabolic enzymes in rat placental bed.
Fonseca BM; Battista N; Correia-da-Silva G; Rapino C; Maccarrone M; Teixeira NA
Reprod Toxicol; 2014 Nov; 49():74-7. PubMed ID: 25088244
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Anandamide Synthesis and Degradation during Osteoarthritis Progression in an Animal Model.
Bryk M; Chwastek J; Kostrzewa M; Mlost J; Pędracka A; Starowicz K
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036283
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes to the endocannabinoid system in models of chronic pain.
Rani Sagar D; Burston JJ; Woodhams SG; Chapman V
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3300-11. PubMed ID: 23108548
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.
Starowicz K; Przewlocka B
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3286-99. PubMed ID: 23108547
[TBL] [Abstract][Full Text] [Related]
19. Anandamide levels fluctuate in the bovine oviduct during the oestrous cycle.
Gervasi MG; Marczylo TH; Lam PM; Rana S; Franchi AM; Konje JC; Perez-Martinez S
PLoS One; 2013; 8(8):e72521. PubMed ID: 23977311
[TBL] [Abstract][Full Text] [Related]
20. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
